[Oral rehydration therapy with OS-1 for advanced and recurrent gastrointestinal cancer patients]. 2010

Taku Nishimura, and Kouichirou Sakata, and Mitsuo Nakamura, and Toshimasa Okada, and Yuko Fukuda, and Shinobu Tanaka, and Masakazu Seiki, and Yumi Takemura, and Satoyoshi Yamashita
Dept. of Gastrointestinal Surgery, Shimonoseki Kousei Hospital.

The aim of this study was to introduce an oral rehydration therapy with OS-1 for advanced and recurrent gastrointestinal cancer patients to reduce a hospital stay as well as having a good QOL. We targeted 10 advanced cancer patients. In this study, We recommended the OS-1 drinking amount to be 500 mL to 1, 000 mL whenever the following symptoms were observed:(1) the patient's meal consumption was decreased in half, (2) the volume of urine was decreased, and (3) the frequency of urine was decreased. Nine out of 10 patients were able to drink OS-1 in the range of 500 mL to 1, 000 mL. Most of the patients were taking the chemotherapy along with OS-1 therapy. We confirmed two distinct cases: The patients with OS- 1 short-term drinker at the time of appetite fall because of chemotherapy. Another case was the patients with OS-1 longterm drinkers due to the end of life stage which decreased in meal frequency. ORT with OS-1 may contribute to improve QOL of the terminal patient with chemotherapy.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D003110 Colonic Neoplasms Tumors or cancer of the COLON. Cancer of Colon,Colon Adenocarcinoma,Colon Cancer,Cancer of the Colon,Colon Neoplasms,Colonic Cancer,Neoplasms, Colonic,Adenocarcinoma, Colon,Adenocarcinomas, Colon,Cancer, Colon,Cancer, Colonic,Cancers, Colon,Cancers, Colonic,Colon Adenocarcinomas,Colon Cancers,Colon Neoplasm,Colonic Cancers,Colonic Neoplasm,Neoplasm, Colon,Neoplasm, Colonic,Neoplasms, Colon
D005260 Female Females
D005440 Fluid Therapy Therapy whose basic objective is to restore the volume and composition of the body fluids to normal with respect to WATER-ELECTROLYTE BALANCE. Fluids may be administered intravenously, orally, by intermittent gavage, or by HYPODERMOCLYSIS. Oral Rehydration Therapy,Rehydration,Rehydration, Oral,Oral Rehydration,Rehydration Therapy, Oral,Therapy, Fluid,Therapy, Oral Rehydration,Fluid Therapies,Oral Rehydration Therapies,Oral Rehydrations,Rehydration Therapies, Oral,Rehydrations,Rehydrations, Oral,Therapies, Fluid,Therapies, Oral Rehydration
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old

Related Publications

Taku Nishimura, and Kouichirou Sakata, and Mitsuo Nakamura, and Toshimasa Okada, and Yuko Fukuda, and Shinobu Tanaka, and Masakazu Seiki, and Yumi Takemura, and Satoyoshi Yamashita
May 2014, Journal of the Chinese Medical Association : JCMA,
Taku Nishimura, and Kouichirou Sakata, and Mitsuo Nakamura, and Toshimasa Okada, and Yuko Fukuda, and Shinobu Tanaka, and Masakazu Seiki, and Yumi Takemura, and Satoyoshi Yamashita
November 1986, Klinicheskaia meditsina,
Taku Nishimura, and Kouichirou Sakata, and Mitsuo Nakamura, and Toshimasa Okada, and Yuko Fukuda, and Shinobu Tanaka, and Masakazu Seiki, and Yumi Takemura, and Satoyoshi Yamashita
June 2004, International journal of clinical oncology,
Taku Nishimura, and Kouichirou Sakata, and Mitsuo Nakamura, and Toshimasa Okada, and Yuko Fukuda, and Shinobu Tanaka, and Masakazu Seiki, and Yumi Takemura, and Satoyoshi Yamashita
September 1980, The Journal of pediatrics,
Taku Nishimura, and Kouichirou Sakata, and Mitsuo Nakamura, and Toshimasa Okada, and Yuko Fukuda, and Shinobu Tanaka, and Masakazu Seiki, and Yumi Takemura, and Satoyoshi Yamashita
September 1980, The Journal of pediatrics,
Taku Nishimura, and Kouichirou Sakata, and Mitsuo Nakamura, and Toshimasa Okada, and Yuko Fukuda, and Shinobu Tanaka, and Masakazu Seiki, and Yumi Takemura, and Satoyoshi Yamashita
November 1985, Military medicine,
Taku Nishimura, and Kouichirou Sakata, and Mitsuo Nakamura, and Toshimasa Okada, and Yuko Fukuda, and Shinobu Tanaka, and Masakazu Seiki, and Yumi Takemura, and Satoyoshi Yamashita
January 2018, ESMO open,
Taku Nishimura, and Kouichirou Sakata, and Mitsuo Nakamura, and Toshimasa Okada, and Yuko Fukuda, and Shinobu Tanaka, and Masakazu Seiki, and Yumi Takemura, and Satoyoshi Yamashita
April 1990, Pediatric clinics of North America,
Taku Nishimura, and Kouichirou Sakata, and Mitsuo Nakamura, and Toshimasa Okada, and Yuko Fukuda, and Shinobu Tanaka, and Masakazu Seiki, and Yumi Takemura, and Satoyoshi Yamashita
June 1995, Lancet (London, England),
Taku Nishimura, and Kouichirou Sakata, and Mitsuo Nakamura, and Toshimasa Okada, and Yuko Fukuda, and Shinobu Tanaka, and Masakazu Seiki, and Yumi Takemura, and Satoyoshi Yamashita
August 1988, New era nursing image international : NENI,
Copied contents to your clipboard!